Enveric Biosciences, Inc. ENVB
Set alert
1.43 USD -0.03 -2.05%
At close · Oct 30
1.43 0.00 0.00%
After hours · Oct 30, 4:00 PM ET
1.40 Day range 1.48
1.27 52-week range 10.33
- YTD
- -60.61%
- 1 year
- -76.67%
- Open
- 1.47
- Prev close
- 1.46
- Mkt cap
- 6.40M
- Vol
- 12.00K
- Avg vol
- 86.31K
- EPS
- -13.01
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.40
- High
- 1.48
- Forward P/E
- -0.22
- Beta
- 0.47
- Short ratio
- 0.31
- Inst. own
- 7.06%
- Dividend
- 0.00
- Ex-div date
- Apr 22, 2008
- 50-d avg
- 0.40876
- 200-d avg
- 0.63229
- 1y target
- 0.00
Financial health
Altman Z-Score
-16.40 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B-2 / 5 overall
- DCF 5
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 5
Valuation
P/E -0.1×
FY 2016 5y median -2.4× FY 2025
P/S 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 0.3×
FY 2016 5y median 4.4× FY 2025
P/FCF -0.1×
FY 2016 5y median -3.0× FY 2025
EV/EBITDA 0.4×
FY 2016 5y median -2.4× FY 2025
EV/Sales 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -670.1%
FY 2016 5y median -33.5% FY 2025
Profitability
Gross Margin 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -290.4%
FY 2016 5y median -219.6% FY 2025
ROIC -210.0%
FY 2016 5y median -210.0% FY 2025
ROA -238.1%
FY 2016 5y median -183.3% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2016 FY 2025
Operating Income 8.9%
FY 2016 FY 2025
EPS (diluted) 84.1%
FY 2016 FY 2025
Free Cash Flow -5.4%
FY 2016 FY 2025
Financial Health
Current Ratio 5.4×
FY 2016 5y median 4.6× FY 2025
Quick Ratio 5.4×
FY 2016 5y median 4.6× FY 2025
Debt / Equity 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.5×
FY 2016 5y median 0.3× FY 2025
Interest Coverage -82778×
FY 2016 5y median -3803× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31